About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Asthma in the Elderly: The Effect of Montelukast

NCT02635334·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.

Age

65–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Asthma diagnosed for at least one year;
Able to swallow small capsules.

You may not be if

Tobacco smoking for more than 10/pack years;
Previous adverse reaction to montelukast or other leukotriene inhibitor;
History of hypereosinophilic disorder other than atopic disease;
Treatment with montelukast within 4 weeks from randomization;
Asthma exacerbation or treatment with prednisone/other systemic steroid within 4 weeks from randomization.

The record

StatusCompleted

PhasePhase 4

Taking part26

StartedNov 2015

UpdatedOct 5, 2016

Conditions

Where1

Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.
Bryn Mawr, Pennsylvania, United States

Clareo Health | Asthma in the Elderly: The Effect of Montelukast